General
Preferred name
CISATRACURIUM BESYLATE
Synonyms
51W89 ()
Cisatracurium Besylate ()
Cisatracurium (besylate) ()
51W89 (besylate) ()
Cisatracurium (besilate) ()
51-W89 ()
Nimbex preservative free ()
Cisatracurium (as besilate) ()
Cisatracurium besilate ()
51-W-89 ()
51 W89 ()
51W-89 ()
Nimbex ()
Cisatracurium besylate preservative free ()
P&D ID
PD009962
CAS
96946-42-8
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
Drug indication
Neuromuscular Blocking Agent
First approval
1995
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
9
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Properties
(calculated by RDKit )
Molecular Weight
1242.5
Hydrogen Bond Acceptors
18
Hydrogen Bond Donors
0
Rotatable Bonds
26
Ring Count
8
Aromatic Ring Count
6
cLogP
9.25
TPSA
240.84
Fraction CSP3
0.42
Chiral centers
4.0
Largest ring
6.0
QED
0.02
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
nicotinic acetylcholine receptor antagonist
Target
Muscle-type nicotinic acetylcholine receptor
AChR
Adrenergic Receptor
nAChR
Pathway
Neuroscience
GPCR/G protein
Autophagy
Membrane Transporter/Ion Channel
Neuronal Signaling
Source data
